Effects of octreotide on lower esophageal sphincter in patients with cirrhosis and portal hypertension.
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 43 (7) , 1566-1571
- https://doi.org/10.1023/a:1018879218508
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.Gut, 1997
- Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive ratsHepatology, 1996
- Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjectsGastroenterology, 1995
- Criteria for objective definition of transient lower esophageal sphincter relaxationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1995
- Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosisGastroenterology, 1992
- Somatostatin stimulation of the normal esophagusThe American Journal of Surgery, 1992
- Peptidergic innervation of the human esophageal smooth muscleGastroenterology, 1991
- Control of belching by the lower oesophageal sphincter.Gut, 1990
- Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux.Gut, 1988
- A Randomized Comparison of Metoclopramide and Domperidone on Plasma Aldosterone Concentration and on Spironolactone–Induced Diuresis in Ascitic Cirrhotic PatientsHepatology, 1985